These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2237567)
1. Hypercalcemia as a clinical prodrome to lymphoma. Krolick MA; Altus P; Foulis PR South Med J; 1990 Nov; 83(11):1331-4. PubMed ID: 2237567 [TBL] [Abstract][Full Text] [Related]
2. Primary non-Hodgkin's lymphoma of liver with humoral hypercalcaemia. Santhosh-Kumar CR; Ajarim DS; Shipkey FD Postgrad Med J; 1990 Aug; 66(778):679-81. PubMed ID: 1699217 [TBL] [Abstract][Full Text] [Related]
3. Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854. Bartlett NL; Petroni GR; Parker BA; Wagner ND; Gockerman JP; Omura GA; Canellos GP; Robert M; Johnson JL; Peterson BA Cancer; 2001 Jul; 92(2):207-17. PubMed ID: 11466671 [TBL] [Abstract][Full Text] [Related]
4. Non-Hodgkin's lymphoma presenting as multiple bone lesions and hypercalcemia. Takasaki H; Kanamori H; Takabayashi M; Yamaji S; Koharazawa H; Taguchi J; Fujimaki K; Ishigatsubo Y Am J Hematol; 2006 Jun; 81(6):439-42. PubMed ID: 16680736 [TBL] [Abstract][Full Text] [Related]
5. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic factors of invasive non-Hodgkin's lymphoma]. Yu H; Hong XN; Li J; Peng LP; Ye L Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):461-3. PubMed ID: 17974284 [TBL] [Abstract][Full Text] [Related]
7. Successful treatment of non-Hodgkin's lymphoma in a patient with common variable immunodeficiency. Ohnoshi T; Hayashi K; Tagawa S; Saito S; Matsutomo S; Kawashima K; Kimura I Intern Med; 1993 Feb; 32(2):152-5. PubMed ID: 7685210 [TBL] [Abstract][Full Text] [Related]
8. A 78-year-old women with hypercalcemia now and malignancy of unknown origin 11 years ago. Royen HI; Westedt ML; den Ottolander GJ; Bieger R Ann Hematol; 1998 Feb; 76(2):95-8. PubMed ID: 9540767 [No Abstract] [Full Text] [Related]
9. The response of diffuse large cell and other intermediate grade non-Hodgkin's lymphomas to adriamycin containing combination chemotherapy. Lishner M; Slingerland J; Theresa C; Sutcliffe SB Leuk Lymphoma; 1994 Mar; 13(1-2):131-6. PubMed ID: 7517744 [TBL] [Abstract][Full Text] [Related]
10. Comparison of a second-generation combination chemotherapeutic regimen (m-BACOD) with a standard regimen (CHOP) for advanced diffuse non-Hodgkin's lymphoma. Gordon LI; Harrington D; Andersen J; Colgan J; Glick J; Neiman R; Mann R; Resnick GD; Barcos M; Gottlieb A N Engl J Med; 1992 Nov; 327(19):1342-9. PubMed ID: 1383819 [TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 32 primary intestinal non-Hodgkin's lymphoma]. Bai CM; Yang T; Xü Y; Zhang W; Liu XL; Zhu YL; Chen SC; Shen T Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):142-4. PubMed ID: 16750023 [TBL] [Abstract][Full Text] [Related]
12. High-dose CHOP as initial therapy for patients with poor-prognosis aggressive non-Hodgkin's lymphoma: a dose-finding pilot study. Shipp MA; Neuberg D; Janicek M; Canellos GP; Shulman LN J Clin Oncol; 1995 Dec; 13(12):2916-23. PubMed ID: 8523055 [TBL] [Abstract][Full Text] [Related]
13. A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851. Gottlieb AJ; Anderson JR; Ginsberg SJ; Bloomfield CD; Norton L; Barcos M; Peterson BA; Nissen N; Henderson ES; Holland JF Cancer; 1990 Nov; 66(9):1888-96. PubMed ID: 1699653 [TBL] [Abstract][Full Text] [Related]
14. [Diagnosis and treatment of primary colorectal non-Hodgkin's lymphoma: analysis of 52 cases]. Huang S; Zheng ZX; Xu Q; Yuan XH Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):305-8. PubMed ID: 23985262 [TBL] [Abstract][Full Text] [Related]
15. Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective. Coiffier B; Reyes F; Oncology (Williston Park); 2005 Apr; 19(4 Suppl 1):7-15. PubMed ID: 15934513 [TBL] [Abstract][Full Text] [Related]
16. [Clinical features of 89 patients with primary non-Hodgkin's lymphoma of the tonsil]. Qin Y; Shi YK; He XH; Yang JL; Yang S; Yu YX; Li B; Wang QL; Zhou LQ; Sun Y Ai Zheng; 2006 Apr; 25(4):481-5. PubMed ID: 16613685 [TBL] [Abstract][Full Text] [Related]
17. Calcitriol production in hypercalcemic and normocalcemic patients with non-Hodgkin lymphoma. Seymour JF; Gagel RF; Hagemeister FB; Dimopoulos MA; Cabanillas F Ann Intern Med; 1994 Nov; 121(9):633-40. PubMed ID: 7944070 [TBL] [Abstract][Full Text] [Related]
19. Intravascular B-cell lymphoma with hypercalcemia as the initial presentation. Chinen Y; Nakao M; Sugitani-Yamamoto M; Kiyota M; Horiike S; Kuroda J; Taniwaki M Int J Hematol; 2011 Dec; 94(6):567-70. PubMed ID: 22045306 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of Hypercalcemia in Non-Hodgkin Lymphoma and Associated Outcomes: A Retrospective Review. Shallis RM; Rome RS; Reagan JL Clin Lymphoma Myeloma Leuk; 2018 Feb; 18(2):e123-e129. PubMed ID: 29361495 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]